Hypercholesterolemia

LA JOLLA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it…

CAMBRIDGE, Mass., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today…

Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class active immunotherapy with plans to bring…

is a condition in which low-density lipoprotein (LDL) levels elevate in the blood. The complications related to this disorder include atherosclerosis and heart disease at an early age. It is a genetic disorder that affects 320,000 people…

The majority of familial hypercholesterolemia (FH) cases would go undetected if people relied on array-based genetic tests alone, according to…